The German CARISMED GROUP has consolidated its global worldwide operations with German MIRAmedtech UG and U.S. based eMIRAmed to accelerate innovation on behalf of clients ​

"The consolidation of Germany based CARISMED operations with both MIRAmedtech (Germany) and eMIRAmed (USA) is a natural next step in our journey to better serve the Aesthetic and Medical community at large, significantly expand the R&D, better manage risk and capital,” said Serge Castro, Founder and CEO.

“This transaction combines synergies, increases efficiency, reduces costs and accelerates all of our projects by providing our combined teams the opportunity to drive innovation more quickly and deliver more value to our distributors and our end-users.”